Annual review of systemic disease--1997--II.
The intention of this series of semiannual reviews of systemic diseases is not to develop an annual encyclopedic compendium of every article published in the prior calendar year on each systemic illness but rather to select for each issue a few systemic diseases of import to the neuro-ophthalmologist, and to summarize the literature that has developed over the past few years. For each systemic disease selected, the review will cover new developments in its epidemiology; new reports of its neuro-ophthalmic, ocular, and neurologic manifestations; unique clinical presentations; radiologic and laboratory diagnostic tools; and new therapies available to the neuro-ophthalmologist. If appropriate, new information on the etiology of the illness will be reported. In this installment, progress in the clinical recognition and treatment of tuberculosis, sarcoidosis, and human immunodeficiency virus- (nonretinal) related illness is discussed.
Lama
P
P
Department of Ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, USA.
Frohman
L
L
D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D015828:Eye Infections, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D012507:Sarcoidosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014392:Tuberculosis, Ocular / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*